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RESPONSIVENESS OF LATERAL COMPARTMENT JOINT SPACE WIDTH:
DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI)
R.L. Russell y, J. Lynch z, M. Nevitt z, J. Duryea y. yBrigham and Women’s
Hosp., Boston, MA, USA; zUniv. of California San Francisco, San
Francisco, CA, USA
Purpose: An important structural measure of OA progression is radio-
graphic joint space width (JSW). Although a substantial fraction of
knees have lateral compartment OA, this compartment is much less
studied. As an example, the knee radiographs for the OAI were acquired
with a protocol designed for the medial compartment, therefore
measurements of lateral compartment JSW are potentially less reliable.
Furthermore, JSW measurement covering the full extent of the lateral
compartment could not be made for a substantial fraction of the knees
due to sub optimal positioning for the lateral compartment. Previous
work has conﬁrmed themost responsive location tomeasure JSW in the
medial compartment as a function of x, a dimensionless variable
derived from an anatomical coordinate system. An analogous location
in the lateral compartment has not been determined, and currently
lateral compartment JSW readings for the OAI have been deemed
“experimental”. The goal of this project was to determine the most
responsive locations in the lateral compartment to measure JSW loss in
patients with lateral compartment disease.
Methods: We selected all patients from the OAI with knee radiographs
available for the baseline (BL) and 48 month visits, BL Kellgren Law-
rence score of 2 or 3, and greater joint space narrowing in the lateral
compartment than the medial compartment based on the OARSI JSN
score. Exclusion criteria were the presence of TKR and inconsistent
positioning of the knee as determined by the tibial alignment (OAI
variable TPCFDS), a measure of the distance between the projected tibia
rim and plateau. A change of greater than 2mm was grounds for
exclusion. These criteria provided 326 knees from 278 unique IDs.
Results: Complete coverage of the tibial plateau (deﬁned as x¼ 0.700 to
0.900) was available for 283 out of 326 knees (86%). A secondary
analysis was performed including knees (N ¼ 300, 92%) with partial
coverage (deﬁned as x ¼ 0.700 to 0.775). (Row 5 of the table) The
location x ¼ 0.725 provided the most responsive measure of JSW for all
groups, but the responsiveness was substantially uniform from x ¼
0.700 to x ¼ 0.775.
Conclusions: In patients with lateral OA we found that the most
responsive measure of JSW was in the inner portion of the compart-
ment (between x¼ 0.700 and x¼ 0.775) as measured by the SRM value.
In this range there was little variation in SRM value, so each location
provides a comparably responsive measure. An examination of the two
SRM components revealed that improved performance in the x ¼ 0.700
to x ¼ 0.775 was due to a reduced standard deviation rather than
increased joint space loss. This suggests that this region provides a more
reliable measurement rather than reﬂecting more change. This study
marks a step toward understanding the best way to measure JSW in
patients with lateral compartment knee OA.Table. SRM values at ﬁxed locations (x) along lateral compartment of the knee. N/A corresponds to missing values due to lack of coverage for all knees
x ¼ 0.700 x ¼ 0.725 x ¼ 0.750 x ¼ 0.775 x ¼ 0.800 x ¼ 0.825 x ¼ 0.850 x ¼ 0.875 x ¼ 0.900
All (N ¼ 283) -0.99 -1.06 -1.03 -0.98 -0.95 -0.90 -0.86 -0.83 -0.85
KL2 (N ¼ 157) -0.94 -0.99 -0.95 -0.87 -0.83 -0.80 -0.79 -0.79 -0.81
KL3 (N ¼ 12 6) -1.06 -1.16 -1.14 -1.15 -1.14 -1.07 -0.96 -0.90 -0.91
Including partial (N ¼ 300) -0.94 -1.00 -0.97 -0.92 N/A N/A N/A N/A N/A100
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Purpose: In order to understand the pathophysiology of osteoarthritis
(OA) its mediators need to be identiﬁed. Synovial ﬂuid (SF) is a joint
located serum ﬁltrate with additional contributions from articularcartilage, synovium and bone. It represents a potential source of dis-
ease speciﬁc proteins that could aid in the understanding of the
pathogenesis of joint disease and be used in the early diagnosis of
disease. Mass spectrometry (MS) provides opportunities to discover
disease mechanisms whilst simultaneously identifying potential bio-
markers of OA. In MS high abundance proteins interfere with the
signal from low abundance proteins; the fraction containing most
potential proteins of interest. To overcome this methods of protein
depletion or equalisation have been used. However in SF proteomics
only protein depletion using expensive immunodepletion columns
has been implemented. We therefore investigated the use of a more
cost effective equalisation method using Proteominer beads in order
to comprehensively proﬁle the protein complement of SF in health and
OA using liquid chromatography mass spectrometry (LC-MS/MS).
Additionally label-free quantiﬁcation identiﬁed potential OA
biomarkers.
Methods: Following the collection of SF from the meta-
carpophalangeal joints of 9 normal and 9 OA racing thoroughbred
horses macroscopic, microscopic and synovitis scoring was under-
taken. SF was hyaluronidase treated and high abundant proteins
depleted using ProteoMiner equalisation beads. Reduction, alkyla-
tion and trypsin digestion were undertaken directly on the beads after
equal protein loading. To investigate the efﬁciency of ProteoMiner
technology a single SF sample was analysed without protein depletion.
All samples were individually analysed on a two hour gradient with
LC-MS/MS using a NanoAcquity LC coupled to a LTQ Orbitrap Velos.
Progenesis LC-MS software was used for label-free quantiﬁcation
with data searched for protein identiﬁcations using Mascot in the
Ensembl database for horse. To maximise the number of quantiﬁable
protein with an acceptable false discovery rate (FDR) the peptide
matches were adjusted to 1% FDR prior to the protein identiﬁcations
being re-imported into Progenesis. Adjusted ANOVA values of
p<0.05 and additionally regulation of >2-fold were regarded as
signiﬁcant.
Results: The average modiﬁed Mankins score, palmar osteochondral
disease score and synovitis scores for normal samples were 0.8 0.35, 0
and 1.1  0.2 and OA samples were 13.6  1.4, 1.7  0.2, 2.3  0.2 (mean
 standard error mean). The number of protein identiﬁcations was
increased by 33% in the Proteominer treated SF compared to unde-
pleted SF. Following Proteominer treatment and Progenesis analysis
a total of 754 proteins were identiﬁed in SF, 593 with a signiﬁcant
Mascot score. Thus Proteominer beads concentrated the lower
abundance proteins enabling the most comprehensive SF proteome to
date. Proteins identiﬁed included those relating to matrix proteins,
inﬂammatory factors, complement activation proteins and proteases. A
subset of 10 proteins were identiﬁed which were differentially
expressed in OA SF (Table 1).
Conclusions: A number of proteins were identiﬁed for the ﬁrst time
in SF which may be involved in the pathogenesis of OA. We identiﬁed
a distinct set of proteins that may act as potential biomarkers to
distinguish between normal and OA joints. S100-A10, a calciumbinding protein has upregulated in OA. Other S100 proteins have
been demonstrated as having a role in the pathogenesis of OA and in
SF proteomic studies. However this is the ﬁrst time S100-A10 has
been implicated in OA. Together with its binding partner annexin 2 it
acts as a plasminogen receptor and regulates plasminogen-depend-
ant macrophage activation. This may have a role in the synthesis and
activation of matrix degrading proteases. CD109 is a TGF-b co-
receptor, released from the chondrocyte cell surface that inhibits
TGF-b signalling. Its contribution to the disregulation of TGF-b is
unknown.
